Evaluation of the protection induced by avian influenza vaccines containing a 1994 Mexican H5N2 LPAI seed strain against a 2008 Egyptian H5N1 HPAI virus belonging to clade 2.2.1 by means of serological and in vivo tests

Avian Pathology

Volumn 39, Issue 3, 2010, Pages 215-222

  Terregino, Calogero ^a   Toffan, Anna ^a   Cilloni, Filippo ^a   Monne, Isabella ^a   Bertoli, Elena ^a   Castellanos, Lilia ^b   Amarin, Nadim ^b   Mancin, Marzia ^a   Capua, Ilaria ^a  

^a ISTITUTO ZOOPROFILATTICO SPERIMENTALE DELLE VENEZIE   (Italy)

^b Zona Industrial   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; VIRUS VACCINE;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; AVIAN INFLUENZA; CHICKEN; EGYPT; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H5N2; ISOLATION AND PURIFICATION; POULTRY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS SHEDDING; INFLUENZA IN BIRDS;

ANIMALS; ANTIBODY FORMATION; CHICKENS; EGYPT; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA IN BIRDS; POULTRY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, INACTIVATED; VIRAL VACCINES; VIRUS SHEDDING;

AVES;

EID: 77953639207     PISSN: 03079457     EISSN: 14653338     Source Type: Journal    
DOI: 10.1080/03079451003781858     Document Type: Article

References (25)

1. Bos M.E., Nielen, M., Koch, G., Stegeman, A. & De Jong, M.C. (2008). Effect of H7N1 vaccination on highly pathogenic avian influenza H7N7 virus transmission in turkeys. Vaccine, 26, 6322-6328.
2. Capua, I. & Alexander, D.J. (2004). Avian influenza: recent developments. Avian Pathology, 33, 393-404.
3. Capua, I. & Marangon, S. (2004). Vaccination for avian influenza in Asia. Vaccine, 22, 4137-4138.
4. Capua, I., Cattoli, G. & Marangon, S. (2004). DIVA-A vaccination strategy enabling the detection of field exposure to avian influenza. In A. Schudel & M. Lombard (Eds.). Proceedings of Control of Infectious Animal Diseases by Vaccination Developments in Biologicals vol. 119 (pp. 229-233). Karger: Basel.
5. Capua, I., Terregino, C., Cattoli, G. & Toffan, A. (2004). Increased resistance of vaccinated turkeys to experimental infection with an H7N3 low-pathogenicity avian influenza virus. Avian Pathology, 33, 158-163.
6. Capua, I., Terregino, C., Cattoli, G., Mutinelli, F. & Rodriguez, J.F. (2003). Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathology, 32, 47-55.
7. Decision 2006/437/CE (2006). Approving a Diagnostic Manual for Avian Influenza as Provided for in Council Directive 2005/94/EC. Official Journal of the European Union, L237/1, 17.
8. European Medicine Agency, London, UK (2006). Guidelines on requirements for vaccines for use in birds against avian influenza. Doc. Ref. EMEA/CVMP/IWP/222624/2006, 20 July. London.
9. EU Commission (n.d.). Food safety: diagnostic techniques and vaccines for foot and mouth disease, classical swine fever, avian influenza and some other important OIE list A diseases. Report of the Scientific Committee on Animal Health and Animal Welfare. Available online at: http://europes.eu.int/comm/food/fs/sc/scah/out93.
10. Imai, K., Nakamura, K., Mase, M., Tsukamoto, K., Imada, T. & Yamaguchi, S. (2007). Partial protection against challenge with the highly pathogenic H5N1 influenza virus isolated in Japan in chickens infected with the H9N2 influenza virus. Archives of Virology, 152, 1395-1400.
11. Khalenkov, A., Perk, S., Panshin, A., Golender, N. & Webster, R.G.V. (2009). Modulation of the severity of highly pathogenic H5N1 influenza in chickens previously inoculated with Israeli H9N2 influenza viruses. Virology, 383, 32-38.
12. Maas, R.A., Oei, H.L., Kemper, S., Koch, G. & Visser, L. (1998). The use of homologous virus in the haemagglutination-inhibition assay after vaccination with Newcastle disease virus strain La Sota or Clone30 leads to an over estimation of protective serum antibody titres. Avian Pathology, 27, 625-631.
13. Office International des Epizooties, Paris, France (2008a). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: Newcastle Disease. Chapters 2, 3, 14.
14. Office International des Epizooties, Paris, France (2008b). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals: Avian Influenza. Chapters 2, 3, 4.
15. Poetri, O.N., Bouma, A., Murtini, S., Claassen, I., Koch, G., Soejoedono, R.D., van Boven, M., et al. (2009). An inactivated H5N2 vaccine reduces transmission of highly pathogenic H5N1 avian influenza virus among native chickens. Vaccine, 27, 2864-2869.
16. Price, G.E., Soboleski, M.R., Lo, C.Y., Misplon, J.A., Pappas, C., Houser, K.V., Epstein, S.L., et al. (2009). Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses. Vaccine, 27, 6512-6521.
17. Reed, L.J. & Muench, H. (1938). A simple method of estimating fifty percent endpoints. American Journal of Hygiene, 27, 493-497.
18. Spackman, E., Senne, D.A., Myers, T.J., Bulaga, L.L., Garber, L.P., Perdue, M.L., Suarez, D.L., et al. (2002). Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. Journal of Clinical Microbiology, 40, 3256-3260.
19. Swayne, D.E., Beck, J.R. & Mickle, T.R. (1997). Efficacy of recombi- nant fowl poxvirus vaccine in protecting chickens against a highly pathogenic Mexican-origin H5N2 avian influenza virus. Avian Diseases, 41, 910-922.
20. Swayne, D.E., Lee, C.W. & Spackman, E. (2006). Inactivated North American and European H5N2 avian influenza virus vaccines protect chickens from Asian H5N1 high pathogenicity avian influenza virus. Avian Pathology, 35, 141-146.
21. Terregino, C., Toffan, A., Beato, M.S., De Nardi, R., Drago, A. & Capua, I. (2007). Conventional H5N9 vaccine suppresses shedding in specific-pathogen-free birds challenged with HPAI H5N1 A/chicken/ Yamaguchi/7/2004. Avian Diseases, 51, 495-497.
22. Tompkins, S.M., Zhao, Z.S., Lo, C.Y., Misplon, J.A., Liu, T., Ye, Z., Epstein, S.L., et al. (2007). Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerging Infectious Diseases, 13, 426-435.
23. Van der Goot, J.A., Van Boven, M., Stegeman, A., Van de Water, S.G., De Jong, M.C. & Koch, G. (2008). Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine. Virology, 382, 91-97.
24. World Health Organization/World Organisation for Animal Health/ Food and Agriculture Organization H5N1 Evolution Working Group. (2008). Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1) [conference summary]. Emerging Infectious Diseases. Available online at: http://www.cdc.gov/EID/content/14/7/e1.htm. [DOI:10.3201/eid1407.071681] (accessed 2 October 2009).
25. Zhirnov, O.P., Isaeva, E.I., Konakova, T.E., Thoidis, G., Piskareva, L.M., Akopova, I.I., Shneider, A.M., et al. (2007). Protection against mouse and avian influenza A strains via vaccination with a combination of conserved proteins NP, M1 and NS1. Influenza and Other Respiratory Viruses, 1, 71-79.